Cocrystal Pharma, Inc. (COCP): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2012-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$9.97M
Year ended 2012-12-31
2010-12-31: $8.43M2011-12-31: $9.92M2012-12-31: $9.97M$9.97M
2010-12-31 Cost of Revenue (USD) 2012-12-31
Period endedCost of RevenueChange YoYSource filing
2012-12-31$9.97M+0.5%2013-04-01, From 2012-01-01
2011-12-31$9.92Mn/c2013-04-01, From 2011-01-01
2010-12-31$8.43Mn/a2012-04-16, From 2010-01-01